Banco Macro S.A. · BMA · 5 MIN READ

Banco Macro Beats Three Straight, Yet UBS Cuts Target

Banco Macro has beaten earnings estimates three consecutive times, with the latest surprise reaching 27.2%, yet UBS Group cut its price target within the past week. The analyst move reflects a deep di

Banco Macro Beats Again, But UBS Cuts Target

Three consecutive earnings beats, the last one registering a 27.2% positive surprise, and Banco Macro S.A. (BMA) is still trading below where a company director bought shares seven months ago. UBS Group cut its price target on BMA within the past week, a move that runs directly against the trajectory of the underlying numbers, and that gap between operational momentum and market indifference is the story worth examining.

Banco Macro S.A. (BMA) stock analysis
Image: Basis Report
The numbers
  • BMA shares at $62.92, more than 40% below the $101.25, $105.43 analyst consensus target range
  • Three straight earnings beats: 44.7%, 3.4%, then 27.2% above consensus
  • Director Marcos Brito purchased 1,500 shares at $68.27 in March 2026, still above today's price
BMA 90-day price and volume, Jul 22 to Oct 19$80.28$97.63this story$62.92Jul 22Sep 3Oct 19
BMA 90-day price and volume, Jul 22 to Oct 19. Chart: Basis Report · market data at publish.

Three Beats, Zero Recovery

After a rough period, four quarters ago BMA missed estimates by 136.3%, the Buenos Aires-based bank has rebuilt its credibility quarter by quarter. It serves retail customers across savings accounts, consumer loans, mortgages, and credit cards, while also running a corporate book covering foreign trade finance and cash management for Argentine businesses. The 27.2% beat in the most recent quarter was the strongest in the streak, not a fading signal. Yet BMA's trailing twelve-month EPS of $4.89 implies a price-to-earnings ratio of roughly 12.9x at current prices, the kind of multiple that reflects deep skepticism about earnings sustainability, not a market rewarding a turnaround.

What UBS's Cut Reveals

When an analyst trims a price target on a stock already trading more than 40% below consensus, the message is not about near-term earnings, it is about the discount rate applied to any Argentine institution. Director Brito's open-market purchase of 1,500 shares at $68.27 per share in March 2026, per the Form 4 filing, is still underwater at the current $62.92 price, meaning BMA has not returned to that insider's cost basis despite three consecutive beats. Low institutional ownership at 12.1% and short interest of just 3.1% of float suggest this is less a contested short thesis than a stock the market has simply set aside.

HOW BMA STACKS UP, data at publish
TickerMkt capFwd P/E52-wk
BMA$4.0B5.8x+18.2%
GGAL$5.9B5.0x+9.2%
PAM$4.3B6.8x+34.4%
SUPV$672M5.6x+14.3%
BBAR$2.6B17.1x+33.1%
YPF$19.9B9.2x+105.1%

The Number to Watch

The specific test for this thesis is whether the next reported quarter sustains, or extends, the beat streak while revenue growth, currently running at 1.2% on a trailing basis, shows any acceleration. If BMA posts a fourth consecutive positive surprise and the gap to the $101, $105 consensus target does not narrow, that would confirm Argentina macro risk is doing the discounting work regardless of the bank's execution. A miss, by contrast, would validate the UBS cut as prescient rather than premature. Run the free Banco Macro S.A. deep-dive → Banco Macro S.A.'s latest numbers to track the setup into next quarter.

Current fundamentals, valuation and filing history for Banco Macro S.A. (BMA) are tracked on its Basis Report page.

Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.

Frequently Asked Questions

Why is Banco Macro stock cheap despite beating earnings?

Banco Macro beat earnings estimates three consecutive times in a row, yet the stock trades at roughly 12.9x P/E and 40% below analyst consensus targets. UBS cut its price target on the stock, indicating the market applies a deep discount rate to Argentine banking institutions regardless of operational performance.

Did Banco Macro's director buy stock recently?

Director Marcos Brito purchased 1,500 shares at $68.27 per share in March 2026. His purchase is currently underwater, as the stock has not returned to his cost basis despite the company's three consecutive earnings beats.

What is Banco Macro's revenue growth rate?

Banco Macro's trailing twelve-month revenue growth is running at 1.2%. This metric will be watched closely to determine whether the earnings beat streak reflects sustainable momentum or faces acceleration headwinds.

Who owns Banco Macro shares?

Institutional investors hold 12.1% of Banco Macro, while short interest represents just 3.1% of the float, suggesting the market has set the stock aside rather than actively contested it.

What is the analyst consensus price target?

Analyst consensus for Banco Macro ranges from $101.25 to $105.43 per share, representing over 40% upside from the current price of $62.92.

Banco Macro has beaten analyst earnings estimates in three consecutive quarters — most recently by 27.2% — yet UBS Group cut its price target on the Argentine bank within the past week, and BMA shares remain stuck at $62.92, less than two-thirds of the average analyst consensus target of roughly $101–$105.
ANALYSIS
BMA
Banco Macro S.A.
Banco Macro Beats Three Straight, Yet UBS Cuts Target
3 FREE REPORTS · NO CARD REQUIRED

The Report · BMA

Pull the BMA report

From the same desk that filed this story. This article stays free · 3 reports on the house.

Pull the BMA report →